The University of Colorado School of Medicine is conducting a phase two clinical trial to determine if CBD can reduce symptoms of Parkinson’s disease
Continue reading Phase 2 clinical trial: CBD for Parkinsons
A new phase two clinical trial sponsored by University of California Center for Medicinal Cannabis Research is examining the effects of vaporized-cannabis to treat HIV-related neuropathic pain. Continue reading New clinical trial: Vaping for chronic nerve pain in HIV
Tetra Bio-Pharma and clinical research partner Santé Cannabis conduct first-ever and most exhaustive clinical trial to evaluate safety and efficacy of different doses and ratios of cannabis oils versus placebo for (non-cancer) chronic pain. On track for completion later this fall.
Continue reading Tetra Bio-Pharma first-past-the-post on clinical trial for chronic pain
TetraBioPharma is quickly advancing plans to commercialize its #cannabis-based drug and specially designed vaporizer to treat fibromyalgia after getting approval from the Independent Ethics Board.
Continue reading Tetra Bio-Pharma fibromyalgia treatment one step closer
New cannabis-supply agreements for Aurora’s subsidiary MedReleaf now gives the company a presence from Canada’s west coast to the most eastern part of North America all the way up to North of 60. Continue reading Aurora goes east and north-of-60 with new agreements
Maricann today announced its launch of new product line that will feature four strains under the brand name Kiwi.
Continue reading Maricann launches new product line
Researchers have discovered that cannabis is frequently used to alleviate diarrhea, abdominal pain, and loss of appetite caused by inflammatory bowel disease.
Several clinical trials are planned or underway to assess the effectiveness of THC and CBD in treating these conditions, such a Crohn’s and colitis. Continue reading Can THC treat inflammatory bowel disease? We’re about to find out.
Heath Canada decision to reclassify, to a Phase Two medical device, the @TetraBioPharma inhalation pipe for cannabis medication means that patients suffering cancer pain may soon be able to claim the cost through their private and public insurance plans. Continue reading Health Canada makes Tetra Bio-Pharma cannabis-delivery product a Class Two medical device.
At University of Colorado, approximately 60 people will participate in a clinical trial with hopes that CBD will relieve some of the troubling symptoms of Parkinson’s Disease.
Continue reading Parkinson’s clinical trial in Colorado
A new study published in the medical journal Depression and Anxiety found that one-third of the approximately 1.1 million U.S. military spouses suffer one or more psychiatric conditions. Led by New York University School of Medicine’s Dr. Maria Steenkamp, the … Continue reading New study: Military spouses are hurting too
Pity the pessimistic investor who thought that shorting Aurora was smart. Continue reading Aurora short positions not turning out so well
Recruitment is underway for a clinical trial in Brazil to determine if CBD treatment can improve depressive and anxiety symptoms in individuals with bipolar disease.
Continue reading Could CBD treat bipolar? Clinical trial aims to find out.
Supreme Cannabis today announced that its subsidiary 7ACRES will supply dried cannabis to Tilray for its medical-canannis customers in a deal worth more than $2 million.
Continue reading Supreme Cannabis subsidiary 7Acres to supply Tilray with dried cannabis
A heart clinic in Mexico is planning a clinical trial led by a Professor of Medicine at Cornell University to determine safety of CBD in patients who’ve survived heart failure. Continue reading Clinical trial to assess CBD for heart failure
Harvest One CEO Grant Froese, still in his first 100 days as the chief executive, said the company’s retail strategy will be announced in “the coming weeks.”
Continue reading Harvest One retail strategy to be released in the coming weeks after deal signed with Ontario
Aphria and Canadian bio-technology company Rapid Dose Therapeutics have signed an MOU that Aphria will have exclusive global preferred rights to produce, distribute and sell QuickStrip(TM) products for cannabis markets around the world, once a definitive agreement is signed between the two companies in the near future. Continue reading Aphria signs deal; exclusive global partner for QuickStrip
Charlotte’s Web Holdings blasts past 52-wek high.
Continue reading Charlotte’s Web increases 150% in just 3 weeks
Nothing short of a total mind shift in how we treat addiction will solve the current opioid epidemic. Medical cannabinoids must be part of the solution. Continue reading CBD part of solution to opioid epidemic say New York psychiatry prof & addictions specialist
New York University School of Medicine will conduct the first-ever study to test the hypothesis that oral CBD will reduce alcohol consumption in individuals suffering both PTSD and Alcohol Use Disorder. Continue reading First of its kind study to look at CBD for alcohol use & PTSD
Cannabis extracts control pain, reduce muscle paralysis and stiffness, and even protect the brain from further injury in MS patients, according to a new study out of Rome. Continue reading Mounting evidence that cannabis is good medicine for MS
@WeedMD CEO says its new supply agreements with Ontario is a significant milestone for the cannabis producer and distributor. Continue reading WeedMD gets Ontario supply deal
Children with a severe form of #epilepsy experienced fewer seizures and a better quality of life, according to the first study of its kind.
@Tilray CBD oil was used in the phase 2 clinical trial. Continue reading Tilray’s CBD/THC mixture found safe kids with drug-resistant epilepsy
WeedMD on track to have industry’s largest operating platform by 2019 following “impressive yield” from its Strathroy greenhouse plus expected harvests from 2 new grow rooms over coming weeks & 520,000 sf grow rooms by end Dec. Continue reading WeedMD aims for industry’s largest operating production platforms by 2019
Clinical trials will test CBD as treatment for psychosis and schizophrenia.
Renowned expert from Mount Sinai School of Medicine said findings are consistent with other clinical investigations affirming CBD’s antipsychotic properties.
Continue reading UPDATED: Clinical trials will test CBD as treatment for schizophrenia
New clinical study today announced by Phoenix-based biomed company will explore CBD oral solution on symptoms of early psychosis plus the drive behind excessive eating behaviour that accompanies antipsychotic medication use. Continue reading Clinical study: CBD for psychosis & excessive eating caused by antipsychotics
WeedMD appoints new board director to chair Audit Committee; replaces departing director. Continue reading WeedMD appoints new board director to chair Audit Committee; replaces departing director
@TetraBioPharma today announced a new CBD supply agreement with Alberta-based True North Cannabis.
True North will supply Tetra with high-quality, competitively priced CBD Continue reading Tetra stikes another new deal; True North Cannabis to supply high-quality CBD
With $150 million BMO financing for growth capital in place @Aurora_MMJ further positions itself as global enterprise with strong portfolio of diversified assets.
Deal includes $50M LOC & $250M opinion to upsize Aurora Sky #cannabis Continue reading Aurora closes $150M debt deal with BMO
With cannabis legalization just 6 weeks away, an Environics Research survey commissioned by Organigram found that 60% parents concerned; more than half say not enough info available to youth about risks. Continue reading Canadian parents concerned about legalization of cannabis; say not enough info about risks to kids
Drug company earning multi-millions on MS med containing only 2 ingredients – THC and CBD ready to launch epilepsy drug this fall & now racing to develop CBD drugs for schizophrenia, #autism & other hard-to treat diseases. Continue reading On heels of FDA approval for its CBD epilepsy drug, GW Pharm continues focus on schizophrenia & other “incurable” diseases
In line with its recent marketing push, Tetra Bio-Pharma Inc., has named a new VP Marketing.
Continue reading Tetra steps up its game again; names new VP Marketing
New listing on TSX for American company Charlotte’s Web.
The Canadian IPO is for 52% cent to approximately $100 million. Continue reading Charlotte’s Web $100M rockets past the $7 start in early morning trading after halt
WeedMD ambitious expansion plans fully funded by $43 million cash balance, says Q2 report released today. Continue reading WeedMD expansion funded by $43M in cash. Celebrates first harvest
The only major cannabis producer exclusively listing as a premium offering, @Supreme Cannabis holds supply agreements with 6 provinces.
The company today announced new agreements with Nova Scotia and PEI. Continue reading Supreme Cannabis joins “Big Six” club; New supply agreements & exclusive “premium” listing.
First CBD and THC company in Italy planned as @MaricannInc partners with Italian producer. Centre of excellence for cannabis products also in the works. #cannabis Continue reading First CBD & THC company in Italy; Maricann partners with Italian producer
A bulk cannabis-supply agreement between Namaste and Kelowna-based GreenTec Bio-Pharmaceuticals is giving Namaste subsidiary Cannmart a big leg up in the budding online-sales space as the company will be the first Health-Canada approved License Producer with a “sales only” license. Continue reading Namaste strikes bulk-supply deal to feed online sales; first LP with sales-only licence
Link btwn cannabis and glaucoma known for 25 yrs. Continue reading Seeing in the dark; better night vision after drinking cannabis “tea”
We need to acknowledge the giants of cannabis research and pay homage to their immeasurable contributions. Continue reading The pioneers of cannabis research. Where would we be without them?
“The literature is nearly unanimous in suggesting that cannabinoids and endocannabinoids reduce the progression of cancer in preclinical model systems,” Continue reading Research spanning multiple decades suggests cannabis as potential cancer medicine.
Study: Less emphysema for cannabis smokers but more bouts with bronchitis in heavy smokers. Continue reading Cannabis smokers get less emphysema and do better on breathing tests
Study shows overactive endo-cannabinoid system causes desire to eat while reducing ability to burn off calories. Continue reading Why do we get the munchies and how can we lose weight?
Experimental research shows cannabinoids can protect brain and spinal cord from damage after a stroke.
Continue reading A tale of two mice. Protecting the brain after a stroke, using cannabis
Feeling light-headed or dizzy after marijuana use is one of the first signs that your cardiovascular system is in distress. Fainting is another. Continue reading Can inhaling cannabis be a heart hazard?
The potential healing properties of cannabis are becoming increasingly evident. Hundreds of thousands of studies have been done in search of better treatment for diseases involving just about every system and organ in the body.
Continue reading Fifty years of scientific research
Clues to the anti-headache mechanisms of cannabis can be found by looking at headache conditions that are relieved by reducing intracranial pressure. Dexanabinol, a synthetic cannabinoid, has been found to relieve intracranial pressure and improve outcomes after traumatic brain injury. In addition, a double-blind, placebo-controlled trial of 26 patients found that a synthetic form of THC (Nabilone) was “significantly more effective” than Ibuprofen in reducing pain intensity. It was also suggested that the anti-vomiting properties seen in the treatment of nausea brought on by chemotherapy might also be effective in treating migraine. Copyright Notice ©CannabisFindings.com. 2018. Unauthorized use and/or duplication … Continue reading Man-made THC improves headache in clinical trials
more targeted treatments may help alleviate pain without dangerous side effects such as addiction.
Continue reading Targeting pain
The potential healing properties of cannabis extracts are becoming increasingly evident as scientists seek new and better treatment for diseases involving just about every system and organ in the body. Studies and clinical trials in the hundreds of thousands have been conducted or are underway. Continue reading What scientists know
Aurora’s CanniMed cannabis-oil products to be used in a clinical trial for Parkinson’s disease.
The study will determine the safety and tolerability of three different formulations of the cannabis oil for pain in Parkinson’s patients. Continue reading Clinical trial: CanniMed cannabis oil for Parkinson’s
Tetra’s PPP001 is currently in Phase 3, with the end goal being a DIN,” says Aphria CEO.
“Enormous opportunity” for relationship with Tetra, as supplier and shareholder. Continue reading Aphria CEO shares info on Tetra Bio Pharma during Q1 2019 results
Fibromyalgia patients using cannabis saw dramatic improvement and astonished physicians w/ comments like “This is a miraculous treatment” & “I returned to same person I was before” Continue reading “Miraculous.” Cannabis dramatically improved fibromyalgia symptoms.
Columbia University researchers hoping high-CBD, low-THC strain of cannabis will be well tolerated in patients with aggressive form of brain cancer, #glioblastoma and decrease radiation-induced toxicities and nausea and other symptoms. Continue reading Reducing toxic effects of chemo-radiation in brain cancer patients